DCPH Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own DCPH shares is 247, representing 72.03% of the company's common stock.

BRAIDWELL LP, in the last quarter, reduced its stake in DCPH by -47.87% restricting it's holding to 609.64 thousand shares of worth nearly $9.59M. NORTHERN TRUST CORP also lessened -1.82% of the DCPH shares from its portfolio, reducing its holding to 515.96 thousand shares of worth $8.12M. TWO SIGMA ADVISERS, LP also shunned DCPH shares holding by -7.22% last quarter which brought its holding to 401.2 thousand shares worth $6.31M.

As per its latest 13F filing, FRANKLIN RESOURCES INC increased its stake in DCPH by 100% in the last quarter. The institutional holder raised its holding to 34.74 thousand shares having worth more than $546.41K. MILLENNIUM MANAGEMENT LLC also added 22.21% more shares of DCPH to its portfolio, raising its holding to 797.1 thousand shares of worth $12.54M. PARKMAN HEALTHCARE PARTNERS LLC also increased its DCPH shares holding by 29.98% which brought its holding to 729.23 thousand shares worth $11.47M.

The insider with the most stakes in DCPH is Brightstar Associates LLC , director at the company. Additionally, DCPH stock is highly held by EVP & Chief Medical Officer Sherman Matthew L and Chief Financial Officer Kelly Thomas Patrick among others.

Company executives, directors, and other insiders own 28.48% percent of Deciphera Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which DCPH insiders have sold stock, totaling 0 shares. Insiders that have sold shares include PITMAN JAMA, MARTIN DANIEL C., and SHERMAN MATTHEW L.

There have been 0 transaction(s) during the past 6-months in which Deciphera Pharmaceuticals, Inc. insiders have bought stock, totalling 0 shares

Around 0 Deciphera Pharmaceuticals, Inc. shares are held by insiders, which represents about 28.48% of DCPH stock.

DCPH director, Brightstar Associates LLC holds the largest portfolio of the company's shares. DCPH shares owned by Brightstar total nearly 19.72 million.

ASSENAGON ASSET MANAGEMENT S.A. is the largest institutional owner in DCPH which holds 809.92 thousand shares worth $12.74M or 0.95% of the total DCPH shares outstanding followed by FRANKLIN RESOURCES INC with ownership of 34.74 thousand shares representing 0.04% of the DCPH ownership. MILLENNIUM MANAGEMENT LLC is the third largest stakeholder with 797.1 thousand shares or 0.94% of the ownership worth more than $12.54M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the DCPH is concerned, it is a stock which is not optionable.

Number of DCPH shares short is 3.92M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 86.48M shares of DCPH are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, DCPH has 46.43M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for DCPH is 1.05.